HighTower Advisors
ELGX

HighTower Advisors’s Endologix Inc ELGX Stock Holding History

HighTower Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,018
Closed -$83K – 2632
2019
Q3 		$83K Buy
21,018
+1,000
+5% +$5.81K ﹤0.01% 2184
2019
Q2 		$145K Buy
+20,018
New +$137K ﹤0.01% 2117

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

HighTower Advisors's ELGX Position: Q4 2019 in Review

HighTower Advisors sold out of Endologix Inc (ELGX) in Q4 2019, closing a stake of 21,018 shares — an estimated $83K sold.

HighTower Advisors first reported a position in ELGX in Q2 2019 and held it in 2 quarters. The position peaked at $145K in Q2 2019. 57 funds tracked by Wall St. Rank hold ELGX as of Q4 2019.

  • HighTower Advisors reported no remaining Endologix Inc position as of Q4 2019 after selling out during the quarter.
  • HighTower Advisors sold 21,018 Endologix Inc shares in Q4 2019, an estimated $83K.
  • HighTower Advisors first reported a position in Endologix Inc in Q2 2019 and held it in 2 quarters.
  • HighTower Advisors's Endologix Inc position peaked at $145K in Q2 2019.
  • 57 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2019.

Based on HighTower Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.